SCIENTIFIC EVENTS
IABS – DCVMN Meeting
NGS Testing to Replace In Vivo Adventitious Testing for Old & New Vaccines
June 19-20, 2024
Brussels, Belgium
On invitation only
Vaccination and Surveillance for HPAI in Poultry :
Current Situation and Perspectives
October 22-23, 2024
Paris, France
Learn More
NEWS
Save the date
High Pathogenicity Avian Influenza (HPAI) in poultry, wild birds and wildlife mammals is a global challenge. The spread of the H5Nx 2.3.4.4b lineage of HPAI is now threatening to become truly global…
IABS Retrospective 2023
On behalf of all IABS, we would like to thank you again for your contribution in 2023 and wish you a Happy New Year 2024 !
.
.
President's Column Janvier 2024
Dear IABS Colleagues, Stakeholders, Supporters, and Collaborators,
The transition to the new year is a good time to reflect on our past as we look ahead to 2024…
.
IABS COLLABORATIONS
Inno4Vac – Innovations to accelerate vaccine development and manufacture
Inno4Vac is a public-private partnership that addresses scientific bottlenecks in vaccine development.
It proposes to develop predictive biological and mathematical models of vaccine performance and bio-manufacturing.
The IABS European Affiliate (IABS-EU) is part of consortia and has been selected to drive the regulatory part of the project.
ASFaVIP – African swine fever attenuated live
vaccines in pigs
TESTIMONIALS
Paul Henri Lambert
Professor at University of Geneva
Founder of ADVAC
“I have appreciated the achievements of IABS since many years. It is a unique independent organization that can…
John Petricciani
Past President
Advisor to the Board
“ Cell substrates have been a key element in the evolution of biological products since the…
Kathryn Zoon
“ As a long term US regulator and scientist, I have been working with IABS for many years. The IABS has …
Philippe Duclos
Director ADVAC
University of Geneva
“ A vibrant organization that allows dialogue beyond professional boundaries…